Position in SEER
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,081
-$1,287,029 QoQ
Shares Held
644
-99.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,690,752,415 across 354 Biotechnology names. SEER ranks #320 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in SEER
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,081 | 644 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,288,110 | 703,886 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,528,007 | 704,151 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,506,882 | 704,151 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,190,014 | 704,151 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,626,588 | 704,151 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,387,177 | 704,151 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,191,345 | 709,135 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,342,537 | 706,599 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $8,355,973 | 4,307,203 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $13,584,639 | 6,146,896 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $26,258,671 | 6,149,572 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $26,980,175 | 6,989,683 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $48,690,204 | 8,394,863 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $67,151,023 | 8,675,843 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $78,397,918 | 8,759,544 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $132,675,720 | 8,705,756 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $195,103,851 | 8,553,435 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $293,958,067 | 8,513,121 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $278,451,217 | 8,494,546 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $423,047,001 | 8,457,557 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $424,820,811 | 7,567,168 | Shares | Defined | 2021-02-08 | |
| No filing history on record for this holder in this stock. | ||||||